Evidence map›Paper›PMID 25586602›Full record

SynthesisThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry2015

Cause or Effect? Selective Serotonin Reuptake Inhibitors and Falls in Older Adults: A Systematic Review.

Marie Anne Gebara, Kim L Lipsey, Jordan F Karp, Maureen C Nash, Andrea Iaboni, Eric J Lenze

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05216614 (Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05216614 phase2withdrawnnot on this mapstarted 2021, after this paper: background citation

Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia (FluCOP Trial)

TypeinterventionalSponsorWashington University School of MedicineRan2021 to 2022Enrolled0ConditionsCOVID-19, Olfactory Disorder, ParosmiaArmsFluvoxamine, Placebo
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Antidepressant Use Partially Mediates the Association Between Depression and Risk of Falls and Fall Injuries Among Older Adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  16. Late-life depression: issues for the general practitioner.International journal of general medicine · 2018
    Review
  17. Article
  18. Article
  19. Non-tricyclic and Non-selective Serotonin Reuptake Inhibitor Antidepressants and Recurrent Falls in Frail Older Women.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2016
    Article
  20. Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Marie Anne GebaraDepartment of Psychiatry, University of Pittsburgh School of Medicine, University of Pittsburgh, PA. Electronic address: gebarama@upmc.edu.
Kim L LipseyBernard Becker Medical Library, Washington University, St. Louis, MO.
Jordan F KarpDepartment of Psychiatry, University of Pittsburgh School of Medicine, University of Pittsburgh, PA.
Maureen C NashDepartment of Psychiatry, Oregon Health and Science University School of Medicine, Portland, OR.
Andrea IaboniDepartment of Psychiatry, University of Toronto, Toronto, ON; University Health Network, Toronto, ON.
Eric J LenzeDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO.
University of Pittsburgh · USWashington University in St. Louis · USOregon Health & Science University · USUniversity of Toronto · CA

Funding

Optimizing Care for Older Adults with Back Pain and DepressionR01AG033575 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KARP, JORDAN F · 2010 to 2014
$2.3M
NIA NIH HHS R01 AG033575
6 · The paper itself

Abstract

A 2012 update of the Beers criteria categorizes selective serotonin reuptake inhibitors (SSRIs) as potentially inappropriate medications in all older adults based on fall risk. The application of these recommendations, not only to frail nursing home residents, but to all older adults, may lead to changes in health policy or clinical practice with harmful consequences. A systematic review of studies on the association between SSRIs and falls in older adults was conducted to examine the evidence for causation. Twenty-six studies met the inclusion criteria. The majority of studies were observational and suggest an association between SSRIs and falls. The direction of the relationship--causation or effect--cannot be discerned from this type of study. Standardized techniques for determining likely causation were then used to see if there was support for the hypothesis that SSRIs lead to falls. This analysis did not suggest causation was likely. There is no Level 1 evidence that SSRIs cause falls. Therefore, changes in the current treatment guidelines or policies on the use of SSRIs in older adults based on fall risk may not be justified at this time given the lack of an established evidence base. Given its significance to public health, well-designed experimental studies are required to address this question definitively.

Indexed as

Accidental FallsAgedDepressionHumansInappropriate PrescribingObservational Studies as TopicRandomized Controlled Trials as TopicSelective Serotonin Reuptake InhibitorsSelective Serotonin Reuptake InhibitorsFallsolder adultsSSRI

Identifiers

PMID25586602
PMCPMC4442757
OpenAlexW2140451359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.